Coraxis Patent Expiration

Exclusivity Information

Coraxis holds 1 exclusivity out of which 1 has expired. Details of Coraxis's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
NCI Jun 06, 2018

About Coraxis

Coraxis is a drug owned by ELANCO US INC. Coraxis uses Moxidectin as the active ingredient.

Active Ingredient:

Coraxis uses Moxidectin as the active ingredient. Check out other Drugs and Companies using Moxidectin ingredient.